Abstract
Dendritic cells (DCs) based immunotherapy constitutes a potential tool to induce protective immunity and can act as an adjuvant treatment to antiretroviral therapy in the context of HIV infection. DCs interact with TCD4+ and TCD8+ lymphocytes, presenting antigens and initiating specific immune responses. In turn, the immune microenvironment is also composed of cellular subpopulations asso…